摘要
Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.
| 原文 | 英語 |
|---|---|
| 頁（從 - 到） | 186-194 |
| 頁數 | 9 |
| 期刊 | International Journal of Cardiology |
| 卷 | 219 |
| DOIs | |
| 出版狀態 | 已發佈 - 九月 15 2016 |
指紋
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
引用此文
Pathophysiology of cancer therapy-provoked atrial fibrillation. / Cheng, Wan Li; Kao, Yu Hsun; Chen, Shih Ann; Chen, Yi Jen.
於: International Journal of Cardiology, 卷 219, 15.09.2016, p. 186-194.研究成果: 雜誌貢獻 › 文章
}
TY - JOUR
T1 - Pathophysiology of cancer therapy-provoked atrial fibrillation
AU - Cheng, Wan Li
AU - Kao, Yu Hsun
AU - Chen, Shih Ann
AU - Chen, Yi Jen
PY - 2016/9/15
Y1 - 2016/9/15
N2 - Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.
AB - Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.
KW - Atrial fibrillation
KW - Cancer surgery
KW - Chemotherapy
KW - Proinflammatory cytokines
UR - http://www.scopus.com/inward/record.url?scp=84975252131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84975252131&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2016.06.009
DO - 10.1016/j.ijcard.2016.06.009
M3 - Article
C2 - 27327505
AN - SCOPUS:84975252131
VL - 219
SP - 186
EP - 194
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
ER -